Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ZIVO Bioscience, Inc. (ZIVO : OTC)

• Company Description    Zivo Bioscience Inc., is a R&D firm. It engaged in study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. Zivo Bioscience Inc. is headquartered in Keego Harbor, Michigan. Number of Employees: 5

• Price / Volume Information    Yesterday's Closing Price: $5.00 Daily Weekly Monthly 20 Day Moving Average: 1,177 shares Shares Outstanding: 4.15 (millions) Market Capitalization: $20.76 (millions) Beta: 0.10 52 Week High: $19.65 52 Week Low: $1.11 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 58.73% 57.56% 12 Week 41.64% 37.76% Year To Date -42.53% -46.90%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2125 BUTTERFIELD DRIVE SUITE 100 - TROY,MI 48084 USA ph: 248-452-9866 fax: - tpatel@lhai.com http://www.zivobioscience.com

• General Corporate Information    Officers John B. Payne - Chief Executive Officer; President and Director GuillermoNavarro - Chief Financial Officer Christopher D. Maggiore - Director Laith Larry Yaldoo - Director Alison A. Cornell - Director Peer Information ZIVO Bioscience, Inc. (CORR.) ZIVO Bioscience, Inc. (RSPI) ZIVO Bioscience, Inc. (CGXP) ZIVO Bioscience, Inc. (BGEN) ZIVO Bioscience, Inc. (GTBP) ZIVO Bioscience, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 98978N309 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 4.15 Most Recent Split Date: 10.00 (0.17:1) Beta: 0.10 Market Capitalization: $20.76 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 78.57% vs. Previous Quarter: 68.83% Sales Growth vs. Year Ago Period: 106.25% vs. Previous Quarter: 24.53% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - -1,085.88 12/31/25 - -1,214.86 Current Ratio 06/30/26 - - 03/31/26 - 0.07 12/31/25 - 0.10 Quick Ratio 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.03 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - -5,573.11 12/31/25 - -8,310.86 Book Value 06/30/26 - - 03/31/26 - -0.86 12/31/25 - -0.95 Inventory Turnover 06/30/26 - - 03/31/26 - 0.61 12/31/25 - 1.22 Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - -

Powered by Zacks Investment Research ©